# Antifungal Drugs in Pulmonary Mucormycosis

> **NCT06756191** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Bin Cao** · enrollment: 312 (estimated)

## Conditions studied

- Pulmonary Mucormycosis

## Interventions

- **DRUG:** Combination therapy group
- **DRUG:** Liposomal Amphotericin B

## Key facts

- **NCT ID:** NCT06756191
- **Lead sponsor:** Bin Cao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2025-07-10
- **Final completion:** 2026-12-31
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06756191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06756191, "Antifungal Drugs in Pulmonary Mucormycosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06756191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*